As a new CEO, Thomas Schinicker, who took over Roche Diagnostics Centralized Point of Care Solutions (CPS) in early 2018, he faced a dilemma. HIs executive team had already engaged in a lengthy one-year strategy development process in 2017 mapping out the scenarios for the future and defining where Roche Diagnostics should play and how it should win. All they needed was his sign-off to go ahead and announce the new strategy. What should he do?
Roche Diagnostics: Strategy development (A)
Summary
As a new CEO, Thomas Schinicker, who took over Roche Diagnostics Centralized Point of Care Solutions (CPS) in early 2018, he faced a dilemma. HIs ...
Reference
IMD-7-2175
Copyright
©2021
Copyright owner
IMD Copyright
Organization
Roche Holding
Industry
Healthcare
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Roche Diagnostics: Strategy development (B)
Summary
The CEO decided to hold off on announcing anything before including everyone, all 1600 employees in Roche Diagnostics, in engaging in the strategy ...
Reference
IMD-7-2176
Copyright
©2021
Copyright owner
IMD Copyright
Organization
Roche Holding
Industry
Healthcare
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications
Roche Diagnostics: Strategy development (C)
Summary
Frank Desiere, VP Strategy and Business Development, Roche Diagnostics CPS and his team including Guido Bartalena, Head of Strategy, Roche Diagnost...
Reference
IMD-7-2177
Copyright
©2021
Copyright owner
IMD Copyright
Organization
Roche Holding
Industry
Healthcare
Available Languages
English
Contact
Research Information & Knowledge Hub for additional information on IMD publications